-
Topic
-
Hi all! As most of you know, the HIV Research for Prevention Conference is just around the corner — Oct 28-30 in Cape Town.
I would love to hear who is attending the conference? Please let us know!
As I think we’ve mentioned to the group, we will be officially launching our Online GPP Training Course at R4P — at a reception Thursday evening, 30 Oct, 6:30pm in Hall 2 poster discussion room. Everyone at R4P should definitely plan on attending. It will be an informal session, and we’ll love to have you all in the room to talk about your current experiences in the course.
Please let us know if you’ll be there. Also please circulate any other important or interesting events you know of or are helping organize at the conference!
-
Replies
-
-
-
-
-
-
And as an add on to Rona’s post, you can all stay updated about HIV R4P at AVAC http://www.avac.org/event/hiv-r4p
Or on the blog WhatUpHIV -http://whatsuphiv.blogspot.com/
So far, it’s a great conference— I LOVED that the renowned Bridget Hare included GPP in her plenary presentation this morning, when speaking about working with key populations and ethical trial design. It gave me goose bumps!!
-
From the R4P guide, I have the following information on some posters that may be of interest:
Community Engagement, GPP and Advocacy
Poster Session 01 (Poster Themes 1-26), Wednesday Oct. 29 10:00-11:00 and 17:00-18:30, Level 0, Hall 2
Morar N. Seven Steps to Strengthen Community Engagement in HIV Preventions Trials in Durban. [P02.03]
Broder G, Maynard J, Karuna S, Anude C, Sobieszczyk M, Hammer S. Implementing Good Participatory Practice (GPP) in HVTN505 – the HIV Vaccine Trials Network (HVTN) Experience. [P07.02]
Siskind R, Morar N, Campbell R, Schouten J. Implementing Community Involvement in National Institutes of Health (NIH) HIV/AIDS Clinical Trials Networks. [P07.05]
Research Participants Skills Development as Peer Educators in Their Communities – Morar S., Ramjee G. [P07.06]
Managing Communication and Facilitating the Exchange of Ideas in a Large, Multi-Site Clinical Trial: Experiences from the ASPIRE Study – Scheckter R., Schwartz K., Mayo A., Baeten J., Palanee T., Soto-Torres L., Torjesen K. [P02.01]
A Rectal Revolution Takes a Village: Developing an Educational Video about Rectal Microbicides – Collins, C. Friedland, B., Pickett, J. [P02.02]
How Community Education Tools Facilitated Understanding of the ASPIRE vaginal ring Study: Kampala Experience – Kemigisha D., Ndawula P., Nanyonga S., Nakyanzi T., Etima T., Akello C., Kabwigu S., Nanziri S., Matovu F., Cokley C., White R., Nakabiito C. [P02.04]
Bridging the Gap: Uniting Participants and Staff for Improved ASPIRE Study Metrics at Wits Reproductive Health and HIV Institute in Hillbrow – Reddy K., Rees H., Palanee T. [P02.06]
Retention and Adherence in Trials:
Maximizing Participant Retention in a Phase2B HIV Prevention Trial in Kampala, Uganda: The MTN-003 (VOICE Study) – Muwawu R., Matovu F., Kapaata F., Kikonyogo F., Bukenya R., Musisi J., Kaggwa M., Saava M., Kabwigu S., Nakabiito C. [P23.09]
Recruitment for Retention in Biomedical HIV Prevention Studies: Strategies, Challenges, Lessons Learned from MTN-020 (ASPIRE) Study, at Kampala Site – Nanziri S., Gati B., Nakyanzi T., Matovu F., Etima J., Kabwigu S., Kemigisha D., Nanyonga S., Ndawula P., Nakabiito C. [P23.10]
The Research Registry: A Valuable Strategy for Longitudinal Success in HIV Prevention Research Recruitment – Weinman R., Baker J., Labbett R., Karas S., Riddle S., McGowan I. [P23.18]
Some oral presentations that may be of interest include:
Tuesday October 28th, Presentation OA07.01:
Characteristics of Young Black Men who have sex with Men enrolled in HPTN 061
1:30 PM ‐3:00 PM Location: Level 1, Meeting Room 1.60
Oral Abstract Session 07
Presenters: C. Watson, J. Lucas, S. Fields and D. Wheeler on behalf of the HPTN Black Caucus
Wednesday, October 29th
Presentation OA19.04, The Utilization of Good Participatory Practice (GPP) during the Planning and Implemenation of a PrEP Study among Black MSM
1:30pm -5:00pm, Location: Level 2, Meeting Room 2.40
Oral Abstract Session 19
Presenters: J. Lucas, G. King, P. Watkins, C. Watson, C. Hutchinson, C. Rogers, S. Wakefield, and S. Fields
Thursday, October 30th
Presentation OA28.03: Facing the Realities of HIV Universal Test and Treat: Early Lessons
Learnt from the Delivery of the HPTN 071/PopART Study Intervention
1:30 PM ‐3:00 PM Location: Level 1, Auditorium 2
Oral Abstract Session 28
Presenters: K. Shanaube, S. Griffith, M.Simwinga, C. Ngulube, E. Sakala, S. Simbeza, M. Mutonyi, S. Fidler, R. Hayes, H. Ayles
Thanks so much, Rona.
-
-
Hi Team, will not attend the conference, I would have loved but my skills in in developing/ writing abstracts are very poor.Since I have a team of you, hopefully I will be much better.
Rona, I am excited to learn about the abstracts you co-authored, kindly share with me those on my personal email: jnanyondo @muwrp.org at the write time.
Stacey hope to see you soon!!
Thanks, Jauhara
-
-
Hi all,
I won’t be at the R4P conference but I did co-author an abstract that was accepted for a poster presentation. My colleagues, Russell Campbell and Neetha Morar will be presenting it. Its called Implementing Community Involvement in National Institutes of Health (NIH) HIV/AIDS Clinical Trials Networks and discusses a guidance document that we developed for community engagement. It is very complementary to GPP and the poster notes the value of GPP and other guidance tools for community engagement. Our other network colleagues will be presenting in other sessions on the use of GPP in the NIH-funded HIV/AIDS research networks.
I hope those of you attending enjoy the conference.
-
-
-
-
-
-
-
- The forum ‘GPP Discussion Forum’ is closed to new topics and replies.
